The dopamine D1 receptor availability is reduced in Gilles de la Tourette syndrome: A C-11-SCH23390 PET study

被引：0
|
作者：
Messerschmidt, Konstantin [1 ]
Rullmann, Michael [1 ]
Gkotsoulias, Dimitrios [2 ]
Schmitt, Simon [2 ]
Fremer, Carolin [3 ]
Klages, Carolin [3 ]
Hartung, Kathrin [3 ]
Bujanow, Anna [2 ]
Zientek, Franziska [4 ]
Patt, Marianne [4 ]
Sabri, Osama [1 ]
Mueller-Vahl, Kirsten [3 ]
Moeller, Harald [2 ]
Barthel, Henryk [1 ]
机构：
[1] Univ Leipzig, Dept Nucl Med, Leipzig, Germany
[2] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany
[3] Hannover Med Sch, Clin Psychiat Social Psychiat & Psychotherapy, Hannover, Germany
[4] Univ Leipzig, Dept Nucl Med, Med Ctr, Leipzig, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P597
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Evaluation of the genes for the adrenergic receptors α2A and α1C and Gilles de la Tourette syndrome
    Xu, C
    Ozbay, F
    Wigg, K
    Shulman, R
    Tahir, E
    Yazgan, Y
    Sandor, P
    Barr, CL
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 119B (01): : 54 - 59
  • [42] ATTENUATION OF SCH-23390-INDUCED ALTERATION OF STRIATAL DOPAMINE D1 RECEPTOR ONTOGENY BY PROLYL-LEUCYL-GLYCINAMIDE IN THE RAT
    KOSTRZEWA, RM
    SALEH, MI
    NEUROPHARMACOLOGY, 1989, 28 (08) : 805 - 810
  • [43] Effect of neuropeptide-EI on the binding of [3H]SCH 23390 to the dopamine D1 receptor in rat striatal membranes
    Sanchez, MS
    Salvatierra, NA
    Vettori, G
    Celis, ME
    NEUROCHEMICAL RESEARCH, 2001, 26 (05) : 533 - 537
  • [44] A dopamine D1/5 receptor antagonist, SCH23390, prevents stress-induced sudden death in cardiomyopathic hamsters
    Arakawa, H
    Kodama, H
    Yamaguchi, I
    Matsuoka, N
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 66 (04) : 707 - 712
  • [45] The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors
    Millan, MJ
    Newman-Tancredi, A
    Quentric, Y
    Cussac, D
    PSYCHOPHARMACOLOGY, 2001, 156 (01) : 58 - 62
  • [46] The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors
    Mark J. Millan
    Adrian Newman-Tancredi
    Yann Quentric
    Didier Cussac
    Psychopharmacology, 2001, 156 : 58 - 62
  • [47] PREPARATION OF C-11 LABELED SCH 23390 FOR THE INVIVO STUDY OF DOPAMINE-D-1 RECEPTORS USING POSITRON EMISSION TOMOGRAPHY
    HALLDIN, C
    STONEELANDER, S
    FARDE, L
    EHRIN, E
    FASTH, KJ
    LANGSTROM, B
    SEDVALL, G
    APPLIED RADIATION AND ISOTOPES, 1986, 37 (10) : 1039 - 1043
  • [48] Effect of Neuropeptide-EI on the Binding of [3H]SCH 23390 to the Dopamine D1 Receptor in Rat Striatal Membranes
    M. S. Sanchez
    N. A. Salvatierra
    G. Vettori
    M. E. Celis
    Neurochemical Research, 2001, 26 : 533 - 537
  • [49] Dopamine transporter binding in Gilles de la Tourette syndrome:: a [123I]FP-CIT/SPECT study
    Serra-Mestres, J
    Ring, HA
    Costa, DC
    Gacinovic, S
    Walker, Z
    Lees, AJ
    Robertson, MM
    Trimble, MR
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 109 (02) : 140 - 146
  • [50] A mutation in the human cannabinoid receptor (CNR1)gene in patients with Gilles de la Tourette syndrome.
    Stuhrmann, M
    Gadzicki, D
    Mueller-Vahl, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A44 - A44
12345